Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Eur J Neurosci. 2008 Jul;28(2):299–310. doi: 10.1111/j.1460-9568.2008.06333.x

Table 2.

Design of CRF antagonist experiments

Dorsal raphe pre-infusion Dorsal raphe infusion N
Vehicle (0.5 μL) CRF (0.5 μg/0.5 μL) 6
ASV-30 (2 μg/0.5 μL) CRF (0.5 μg/0.5 μL) 6
Vehicle (0.5 μL) CRF (0.5 μg/0.5 μL) 6
Antalarmin (25 ng/0.5 μL) CRF (0.5 μg/0.5 μL) 6
Antalarmin (50 ng/0.5 μL) CRF (0.5 μg/0.5 μL) 4